Rising role of 3D-printing in delivery of therapeutics for infectious disease
Modern drug delivery to tackle infectious disease has drawn close to personalizing medicine
for specific patient populations. Challenges include antibiotic-resistant infections, healthcare …
for specific patient populations. Challenges include antibiotic-resistant infections, healthcare …
[HTML][HTML] Recent advances in 3D bioprinted neural models: A systematic review on the applications to drug discovery
A Orr, F Kalantarnia, S Nazir, B Bolandi… - Advanced Drug Delivery …, 2025 - Elsevier
The design of neural tissue models with architectural and biochemical relevance to native
tissues opens the way for the fundamental study and development of therapies for many …
tissues opens the way for the fundamental study and development of therapies for many …
[HTML][HTML] Disruptive 3D in vitro models for respiratory disease investigation: A state-of-the-art approach focused on SARS-CoV-2 infection
ML Seixas, CS Bartolomeo, R Lemes… - Biomaterials and …, 2023 - Elsevier
COVID-19, along with most respiratory diseases in the medical field, demonstrates
significant ability to take its toll on global population. There is a particular difficulty in …
significant ability to take its toll on global population. There is a particular difficulty in …
The Relevance of Astrocytic Cell Culture Models for Neuroinflammation in Neurodegeneration Research
AM Preato, ES Pinheiro, TR Rosenstock, I Glezer - Neuroglia, 2024 - mdpi.com
Astrocytes are the predominant glial cells that provide essential support to neurons and
promote microenvironment changes in neuropathological states. Astrocyte and astrocytic …
promote microenvironment changes in neuropathological states. Astrocyte and astrocytic …
Using nanomaterials to address SARS-CoV-2 variants through development of vaccines and therapeutics
MV Hangad, S Keshvani, N Kelpin… - Frontiers in …, 2022 - frontiersin.org
Nanomaterials have played a significant role in effectively combating the global SARS-CoV-
2 pandemic that began in December 2019 through the development of vaccines as well as …
2 pandemic that began in December 2019 through the development of vaccines as well as …